APO Research
Talk to an analyst

APO RESEARCH · REPORT

Critical Illness Insurance

Critical illness insurance, otherwise known as critical illness cover or a dread disease policy, is an insurance product in which the insurer is contracted to typically make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Critical illness insurance, otherwise known as critical illness cover or a dread disease policy, is an insurance product in which the insurer is contracted to typically make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy.

The policy may also be structured to pay out regular income and the payout may also be on the policyholder undergoing a surgical procedure, for example, having a heart bypass operation.

Selected research

Market Outlook & Growth Opportunities

Global Critical Illness Insurance Market Outlook and Growth Opportunities 2026

25 December 2025211 pages

Choose your research edition.

Industry ResearchCritical Illness Insurance Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Critical Illness Insurance Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Critical Illness Insurance Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Critical Illness Insurance Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Critical Illness Insurance Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

Critical illness insurance, otherwise known as critical illness cover or a dread disease policy, is an insurance product in which the insurer is contracted to typically make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy.

The policy may also be structured to pay out regular income and the payout may also be on the policyholder undergoing a surgical procedure, for example, having a heart bypass operation.

Global critical illness insurance key players include China Life Insurance , Ping An Insurance, China Pacific Insurance, etc. Global top three manufacturers hold a share over 35%.

Read the full market overview

China is the largest market, with a share about 50%, followed by North America and Europe, both have a share about 30 percent.

In terms of application, the largest application is Cancer, followed by Heart Attack, Stroke, etc.

This report provides an overview of the global Critical Illness Insurance market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Critical Illness Insurance and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Critical Illness Insurance revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Critical Illness Insurance market.

Critical Illness Insurance Segment by Company

China Life Insurance

Ping An Insurance

China Pacific Insurance

Aviva

Legal & General

New China Life Insurance

AXA

Prudential plc

Aegon

Allianz

AIG

UnitedHealthcare

Zurich

MetLife

Dai-ichi Life Group

Sun Life Financial

Huaxia life Insurance

Aflac

Liberty Mutual

HCF

Generali Group

Royal London

Scottish Windows

Livepool Victoria

Vitality

Critical Illness Insurance Segment by Type

By Type

Fixed-term Insurance

Whole-life Insurance

By Age

<30 Years Old

30-40 Years Old

41-50 Years Old

>50 Years Old

Critical Illness Insurance Segment by Application

Cancer

Heart Attack

Stroke

Other

Critical Illness Insurance Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Critical Illness Insurance status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Critical Illness Insurance key companies, revenue, market share, and recent developments.

3. To split the Critical Illness Insurance breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Critical Illness Insurance market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Critical Illness Insurance significant trends, drivers, influence factors in global and regions.

6. To analyze Critical Illness Insurance competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Critical Illness Insurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Critical Illness Insurance and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Critical Illness Insurance.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Critical Illness Insurance industry.

Chapter 3: Detailed analysis of Critical Illness Insurance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Critical Illness Insurance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Critical Illness Insurance in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Critical Illness Insurance Industry Trends Table 2. Critical Illness Insurance Industry Drivers Table 3. Critical Illness Insurance Industry Opportunities and Challenges Table 4. Critical Illness Insurance Industry Restraints Table 5. Global Critical Illness Insurance Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Critical Illness Insurance Revenue Share by Company (2021-2026) Table 7. Global Critical Illness Insurance Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Critical Illness Insurance Key Company Manufacturing Base & Headquarters Table 9. Global Critical Illness Insurance Company, Product Type & Application Table 10. Global Critical Illness Insurance Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Critical Illness Insurance by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Fixed-term Insurance Table 15. Significant Companies of Whole-life Insurance Table 16. Global Critical Illness Insurance Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Critical Illness Insurance Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Critical Illness Insurance Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Critical Illness Insurance Sales Value Share by Type (2021-2026) Table 20. Global Critical Illness Insurance Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cancer Table 22. Significant Companies of Heart Attack Table 23. Significant Companies of Stroke Table 24. Significant Companies of Other Table 25. Global Critical Illness Insurance Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Critical Illness Insurance Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Critical Illness Insurance Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Critical Illness Insurance Sales Value Share by Application (2021-2026) Table 29. Global Critical Illness Insurance Sales Value Share by Application (2027-2032) Table 30. Global Critical Illness Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Critical Illness Insurance Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Critical Illness Insurance Sales Value Share by Region (2021-2026) Table 33. Global Critical Illness Insurance Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Critical Illness Insurance Sales Value Share by Region (2027-2032) Table 35. Global Critical Illness Insurance Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Critical Illness Insurance Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Critical Illness Insurance Sales Value Market Share by Country (2021-2026) Table 38. Global Critical Illness Insurance Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Critical Illness Insurance Sales Value Market Share by Country (2027-2032) Table 40. China Life Insurance Company Information Table 41. China Life Insurance Business Overview Table 42. China Life Insurance Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. China Life Insurance Critical Illness Insurance Product Portfolio Table 44. China Life Insurance Recent Development Table 45. Ping An Insurance Company Information Table 46. Ping An Insurance Business Overview Table 47. Ping An Insurance Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Ping An Insurance Critical Illness Insurance Product Portfolio Table 49. Ping An Insurance Recent Development Table 50. China Pacific Insurance Company Information Table 51. China Pacific Insurance Business Overview Table 52. China Pacific Insurance Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. China Pacific Insurance Critical Illness Insurance Product Portfolio Table 54. China Pacific Insurance Recent Development Table 55. Aviva Company Information Table 56. Aviva Business Overview Table 57. Aviva Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Aviva Critical Illness Insurance Product Portfolio Table 59. Aviva Recent Development Table 60. Legal & General Company Information Table 61. Legal & General Business Overview Table 62. Legal & General Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Legal & General Critical Illness Insurance Product Portfolio Table 64. Legal & General Recent Development Table 65. New China Life Insurance Company Information Table 66. New China Life Insurance Business Overview Table 67. New China Life Insurance Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. New China Life Insurance Critical Illness Insurance Product Portfolio Table 69. New China Life Insurance Recent Development Table 70. AXA Company Information Table 71. AXA Business Overview Table 72. AXA Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AXA Critical Illness Insurance Product Portfolio Table 74. AXA Recent Development Table 75. Prudential plc Company Information Table 76. Prudential plc Business Overview Table 77. Prudential plc Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Prudential plc Critical Illness Insurance Product Portfolio Table 79. Prudential plc Recent Development Table 80. Aegon Company Information Table 81. Aegon Business Overview Table 82. Aegon Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Aegon Critical Illness Insurance Product Portfolio Table 84. Aegon Recent Development Table 85. Allianz Company Information Table 86. Allianz Business Overview Table 87. Allianz Critical Illness Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Allianz Critical Illness Insurance Product Portfolio Table 89. Allianz Recent Development Table 90. AIG Company Information Table 91. AIG Business Overview Table 92. AIG Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. AIG Critical Illness Insurance Product Portfolio Table 94. AIG Recent Development Table 95. UnitedHealthcare Company Information Table 96. UnitedHealthcare Business Overview Table 97. UnitedHealthcare Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. UnitedHealthcare Critical Illness Insurance Product Portfolio Table 99. UnitedHealthcare Recent Development Table 100. Zurich Company Information Table 101. Zurich Business Overview Table 102. Zurich Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Zurich Critical Illness Insurance Product Portfolio Table 104. Zurich Recent Development Table 105. MetLife Company Information Table 106. MetLife Business Overview Table 107. MetLife Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. MetLife Critical Illness Insurance Product Portfolio Table 109. MetLife Recent Development Table 110. Dai-ichi Life Group Company Information Table 111. Dai-ichi Life Group Business Overview Table 112. Dai-ichi Life Group Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Dai-ichi Life Group Critical Illness Insurance Product Portfolio Table 114. Dai-ichi Life Group Recent Development Table 115. Sun Life Financial Company Information Table 116. Sun Life Financial Business Overview Table 117. Sun Life Financial Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Sun Life Financial Critical Illness Insurance Product Portfolio Table 119. Sun Life Financial Recent Development Table 120. Huaxia life Insurance Company Information Table 121. Huaxia life Insurance Business Overview Table 122. Huaxia life Insurance Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Huaxia life Insurance Critical Illness Insurance Product Portfolio Table 124. Huaxia life Insurance Recent Development Table 125. Aflac Company Information Table 126. Aflac Business Overview Table 127. Aflac Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Aflac Critical Illness Insurance Product Portfolio Table 129. Aflac Recent Development Table 130. Liberty Mutual Company Information Table 131. Liberty Mutual Business Overview Table 132. Liberty Mutual Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Liberty Mutual Critical Illness Insurance Product Portfolio Table 134. Liberty Mutual Recent Development Table 135. HCF Company Information Table 136. HCF Business Overview Table 137. HCF Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. HCF Critical Illness Insurance Product Portfolio Table 139. HCF Recent Development Table 140. Generali Group Company Information Table 141. Generali Group Business Overview Table 142. Generali Group Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 143. Generali Group Critical Illness Insurance Product Portfolio Table 144. Generali Group Recent Development Table 145. Royal London Company Information Table 146. Royal London Business Overview Table 147. Royal London Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 148. Royal London Critical Illness Insurance Product Portfolio Table 149. Royal London Recent Development Table 150. Scottish Windows Company Information Table 151. Scottish Windows Business Overview Table 152. Scottish Windows Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 153. Scottish Windows Critical Illness Insurance Product Portfolio Table 154. Scottish Windows Recent Development Table 155. Livepool Victoria Company Information Table 156. Livepool Victoria Business Overview Table 157. Livepool Victoria Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 158. Livepool Victoria Critical Illness Insurance Product Portfolio Table 159. Livepool Victoria Recent Development Table 160. Vitality Company Information Table 161. Vitality Business Overview Table 162. Vitality Critical Illness Insurance Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 163. Vitality Critical Illness Insurance Product Portfolio Table 164. Vitality Recent Development Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Critical Illness Insurance Product Image Figure 2. Global Critical Illness Insurance Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Critical Illness Insurance Market Size (2021-2032) & (US$ Million) Figure 4. Global Critical Illness Insurance Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Fixed-term Insurance Image Figure 8. Whole-life Insurance Image Figure 9. Global Critical Illness Insurance Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Critical Illness Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Critical Illness Insurance Sales Value Share by Type (2021-2032) Figure 12. Cancer Image Figure 13. Heart Attack Image Figure 14. Stroke Image Figure 15. Other Image Figure 16. Global Critical Illness Insurance Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Critical Illness Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Critical Illness Insurance Sales Value Share by Application (2021-2032) Figure 19. Global Critical Illness Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Critical Illness Insurance Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Critical Illness Insurance Sales Value (2021-2032) & (US$ Million) Figure 22. North America Critical Illness Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Critical Illness Insurance Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Critical Illness Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Critical Illness Insurance Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Critical Illness Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Critical Illness Insurance Sales Value (2021-2032) & (US$ Million) Figure 28. South America Critical Illness Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Critical Illness Insurance Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Critical Illness Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Critical Illness Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Fixed-term Insurance
  • Whole-life Insurance
Applications
  • Cancer
  • Heart Attack
  • Stroke
  • Other
Companies covered
  • China Life Insurance
  • Ping An Insurance
  • China Pacific Insurance
  • Aviva
  • Legal & General
  • New China Life Insurance
  • AXA
  • Prudential plc
  • Aegon
  • Allianz
  • AIG
  • UnitedHealthcare
  • Zurich
  • MetLife
  • Dai-ichi Life Group
  • Sun Life Financial
  • Huaxia life Insurance
  • Aflac
  • Liberty Mutual
  • HCF
  • Generali Group
  • Royal London
  • Scottish Windows
  • Livepool Victoria
  • Vitality

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Critical Illness Insurance Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Critical Illness Insurance Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Critical Illness Insurance Market Dynamics
  1. 2.1 Critical Illness Insurance Industry Trends
  2. 2.2 Critical Illness Insurance Industry Drivers
  3. 2.3 Critical Illness Insurance Industry Opportunities and Challenges
  4. 2.4 Critical Illness Insurance Industry Restraints
3 Critical Illness Insurance Market by Company
  1. 3.1 Global Critical Illness Insurance Company Revenue Ranking in 2025
  2. 3.2 Global Critical Illness Insurance Revenue by Company (2021-2026)
  3. 3.3 Global Critical Illness Insurance Company Ranking (2024-2026)
  4. 3.4 Global Critical Illness Insurance Company Manufacturing Base and Headquarters
  5. 3.5 Global Critical Illness Insurance Company Product Type and Application
  6. 3.6 Global Critical Illness Insurance Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Critical Illness Insurance Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Critical Illness Insurance Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Critical Illness Insurance Market by Type
  1. 4.1 Critical Illness Insurance Type Introduction
  2. 4.1.1 Fixed-term Insurance
  3. 4.1.2 Whole-life Insurance
  4. 4.2 Global Critical Illness Insurance Sales Value by Type
  5. 4.2.1 Global Critical Illness Insurance Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Critical Illness Insurance Sales Value by Type (2021-2032)
  7. 4.2.3 Global Critical Illness Insurance Sales Value Share by Type (2021-2032)
5 Critical Illness Insurance Market by Application
  1. 5.1 Critical Illness Insurance Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Heart Attack
  4. 5.1.3 Stroke
  5. 5.1.4 Other
  6. 5.2 Global Critical Illness Insurance Sales Value by Application
  7. 5.2.1 Global Critical Illness Insurance Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Critical Illness Insurance Sales Value by Application (2021-2032)
  9. 5.2.3 Global Critical Illness Insurance Sales Value Share by Application (2021-2032)
6 Critical Illness Insurance Regional Value Analysis
  1. 6.1 Global Critical Illness Insurance Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Critical Illness Insurance Sales Value by Region (2021-2032)
  3. 6.2.1 Global Critical Illness Insurance Sales Value by Region: 2021-2026
  4. 6.2.2 Global Critical Illness Insurance Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Critical Illness Insurance Sales Value (2021-2032)
  7. 6.3.2 North America Critical Illness Insurance Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Critical Illness Insurance Sales Value (2021-2032)
  10. 6.4.2 Europe Critical Illness Insurance Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Critical Illness Insurance Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Critical Illness Insurance Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Critical Illness Insurance Sales Value (2021-2032)
  16. 6.6.2 South America Critical Illness Insurance Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Critical Illness Insurance Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Critical Illness Insurance Sales Value Share by Country, 2025 VS 2032
7 Critical Illness Insurance Country-level Value Analysis
  1. 7.1 Global Critical Illness Insurance Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Critical Illness Insurance Sales Value by Country (2021-2032)
  3. 7.2.1 Global Critical Illness Insurance Sales Value by Country (2021-2026)
  4. 7.2.2 Global Critical Illness Insurance Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Critical Illness Insurance Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Critical Illness Insurance Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Critical Illness Insurance Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China Life Insurance
  2. 8.1.1 China Life Insurance Company Information
  3. 8.1.2 China Life Insurance Business Overview
  4. 8.1.3 China Life Insurance Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China Life Insurance Critical Illness Insurance Product Portfolio
  6. 8.1.5 China Life Insurance Recent Developments
  7. 8.2 Ping An Insurance
  8. 8.2.1 Ping An Insurance Company Information
  9. 8.2.2 Ping An Insurance Business Overview
  10. 8.2.3 Ping An Insurance Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ping An Insurance Critical Illness Insurance Product Portfolio
  12. 8.2.5 Ping An Insurance Recent Developments
  13. 8.3 China Pacific Insurance
  14. 8.3.1 China Pacific Insurance Company Information
  15. 8.3.2 China Pacific Insurance Business Overview
  16. 8.3.3 China Pacific Insurance Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  17. 8.3.4 China Pacific Insurance Critical Illness Insurance Product Portfolio
  18. 8.3.5 China Pacific Insurance Recent Developments
  19. 8.4 Aviva
  20. 8.4.1 Aviva Company Information
  21. 8.4.2 Aviva Business Overview
  22. 8.4.3 Aviva Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Aviva Critical Illness Insurance Product Portfolio
  24. 8.4.5 Aviva Recent Developments
  25. 8.5 Legal & General
  26. 8.5.1 Legal & General Company Information
  27. 8.5.2 Legal & General Business Overview
  28. 8.5.3 Legal & General Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Legal & General Critical Illness Insurance Product Portfolio
  30. 8.5.5 Legal & General Recent Developments
  31. 8.6 New China Life Insurance
  32. 8.6.1 New China Life Insurance Company Information
  33. 8.6.2 New China Life Insurance Business Overview
  34. 8.6.3 New China Life Insurance Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  35. 8.6.4 New China Life Insurance Critical Illness Insurance Product Portfolio
  36. 8.6.5 New China Life Insurance Recent Developments
  37. 8.7 AXA
  38. 8.7.1 AXA Company Information
  39. 8.7.2 AXA Business Overview
  40. 8.7.3 AXA Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AXA Critical Illness Insurance Product Portfolio
  42. 8.7.5 AXA Recent Developments
  43. 8.8 Prudential plc
  44. 8.8.1 Prudential plc Company Information
  45. 8.8.2 Prudential plc Business Overview
  46. 8.8.3 Prudential plc Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Prudential plc Critical Illness Insurance Product Portfolio
  48. 8.8.5 Prudential plc Recent Developments
  49. 8.9 Aegon
  50. 8.9.1 Aegon Company Information
  51. 8.9.2 Aegon Business Overview
  52. 8.9.3 Aegon Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aegon Critical Illness Insurance Product Portfolio
  54. 8.9.5 Aegon Recent Developments
  55. 8.10 Allianz
  56. 8.10.1 Allianz Company Information
  57. 8.10.2 Allianz Business Overview
  58. 8.10.3 Allianz Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Allianz Critical Illness Insurance Product Portfolio
  60. 8.10.5 Allianz Recent Developments
  61. 8.11 AIG
  62. 8.11.1 AIG Company Information
  63. 8.11.2 AIG Business Overview
  64. 8.11.3 AIG Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AIG Critical Illness Insurance Product Portfolio
  66. 8.11.5 AIG Recent Developments
  67. 8.12 UnitedHealthcare
  68. 8.12.1 UnitedHealthcare Company Information
  69. 8.12.2 UnitedHealthcare Business Overview
  70. 8.12.3 UnitedHealthcare Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  71. 8.12.4 UnitedHealthcare Critical Illness Insurance Product Portfolio
  72. 8.12.5 UnitedHealthcare Recent Developments
  73. 8.13 Zurich
  74. 8.13.1 Zurich Company Information
  75. 8.13.2 Zurich Business Overview
  76. 8.13.3 Zurich Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zurich Critical Illness Insurance Product Portfolio
  78. 8.13.5 Zurich Recent Developments
  79. 8.14 MetLife
  80. 8.14.1 MetLife Company Information
  81. 8.14.2 MetLife Business Overview
  82. 8.14.3 MetLife Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MetLife Critical Illness Insurance Product Portfolio
  84. 8.14.5 MetLife Recent Developments
  85. 8.15 Dai-ichi Life Group
  86. 8.15.1 Dai-ichi Life Group Company Information
  87. 8.15.2 Dai-ichi Life Group Business Overview
  88. 8.15.3 Dai-ichi Life Group Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dai-ichi Life Group Critical Illness Insurance Product Portfolio
  90. 8.15.5 Dai-ichi Life Group Recent Developments
  91. 8.16 Sun Life Financial
  92. 8.16.1 Sun Life Financial Company Information
  93. 8.16.2 Sun Life Financial Business Overview
  94. 8.16.3 Sun Life Financial Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sun Life Financial Critical Illness Insurance Product Portfolio
  96. 8.16.5 Sun Life Financial Recent Developments
  97. 8.17 Huaxia life Insurance
  98. 8.17.1 Huaxia life Insurance Company Information
  99. 8.17.2 Huaxia life Insurance Business Overview
  100. 8.17.3 Huaxia life Insurance Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Huaxia life Insurance Critical Illness Insurance Product Portfolio
  102. 8.17.5 Huaxia life Insurance Recent Developments
  103. 8.18 Aflac
  104. 8.18.1 Aflac Company Information
  105. 8.18.2 Aflac Business Overview
  106. 8.18.3 Aflac Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aflac Critical Illness Insurance Product Portfolio
  108. 8.18.5 Aflac Recent Developments
  109. 8.19 Liberty Mutual
  110. 8.19.1 Liberty Mutual Company Information
  111. 8.19.2 Liberty Mutual Business Overview
  112. 8.19.3 Liberty Mutual Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Liberty Mutual Critical Illness Insurance Product Portfolio
  114. 8.19.5 Liberty Mutual Recent Developments
  115. 8.20 HCF
  116. 8.20.1 HCF Company Information
  117. 8.20.2 HCF Business Overview
  118. 8.20.3 HCF Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  119. 8.20.4 HCF Critical Illness Insurance Product Portfolio
  120. 8.20.5 HCF Recent Developments
  121. 8.21 Generali Group
  122. 8.21.1 Generali Group Company Information
  123. 8.21.2 Generali Group Business Overview
  124. 8.21.3 Generali Group Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Generali Group Critical Illness Insurance Product Portfolio
  126. 8.21.5 Generali Group Recent Developments
  127. 8.22 Royal London
  128. 8.22.1 Royal London Company Information
  129. 8.22.2 Royal London Business Overview
  130. 8.22.3 Royal London Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Royal London Critical Illness Insurance Product Portfolio
  132. 8.22.5 Royal London Recent Developments
  133. 8.23 Scottish Windows
  134. 8.23.1 Scottish Windows Company Information
  135. 8.23.2 Scottish Windows Business Overview
  136. 8.23.3 Scottish Windows Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Scottish Windows Critical Illness Insurance Product Portfolio
  138. 8.23.5 Scottish Windows Recent Developments
  139. 8.24 Livepool Victoria
  140. 8.24.1 Livepool Victoria Company Information
  141. 8.24.2 Livepool Victoria Business Overview
  142. 8.24.3 Livepool Victoria Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Livepool Victoria Critical Illness Insurance Product Portfolio
  144. 8.24.5 Livepool Victoria Recent Developments
  145. 8.25 Vitality
  146. 8.25.1 Vitality Company Information
  147. 8.25.2 Vitality Business Overview
  148. 8.25.3 Vitality Critical Illness Insurance Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Vitality Critical Illness Insurance Product Portfolio
  150. 8.25.5 Vitality Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst